Researchers from the University of Oxford’s Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine.
Influenza is thought to be a highly variable virus, able to mutate and escape immunity built up in the population due to its circulation in previous seasons. However, influenza seasons tend to be dominated by a limited number of antigenically and genetically distinct influenza viruses. This creates a paradox as influenza is thought of as being highly variable while in reality influenza seasons are dominated by only a few strains.
Mathematical models produced in Professor Sunetra Gupta’s group at the University of Oxford over the past 20 years have sought to find an answer to this paradox. Finally, through a collaborative approach across multiple departments, the group believes they have the answer, demonstrated in a paper published today in Nature Communications.
Dr Craig Thompson said: ‘The integrated approach to vaccine design that we have applied to flu has to the potential to be applied to other previously intractable pathogens and could revolutionise the way we develop vaccines.’
Professor Sunetra Gupta said: ‘I think this work serves a good example of how evolutionary models can have translational impact. We have gone from a prediction of a mathematical model to a blueprint for a universal influenza vaccine. The outstanding teamwork coordinated by Dr Thompson is what made it all possible.’
The research team theorized that parts of the virus targeted by the immune system are, in fact, limited in variability and act as constraints on the evolution of the virus. Dr Craig Thompson in Professor Gupta’s group has now identified the location of these regions of limited variability. He has shown that such locations are targeted naturally by the immune system and through vaccination studies has shown that regions of influenza viruses that circulated in 2006 and 1977 were able to protect against infection with an influenza virus that last circulated in 1934.
The results of these studies can be exploited to create a novel type of ‘universal’ or broadly protective influenza vaccine, which once administered would provide lifelong protection against influenza. The team also hopes to apply the approach to other viruses such as HIV and HCV and believes that they can use it to produce a vaccine that protects against the common cold. The novel approach to vaccine design is outlined in the paper published in Nature Communications. Furthermore, such vaccines should be able to be produced in a low-cost manner, enabling healthcare providers such as the NHS to save money, unlike many new vaccines and drugs coming to the market.
This study also presents one of the first examples of where a mathematical model of the evolutionary dynamics of an infectious disease has led to the experimental identification of a novel vaccine target. The novel approach won an MRC Confidence in Concept Award in 2016, a Royal Society Translational Award in 2017 and an ERC Proof of Concept grant in 2018.
The WHO estimates that influenza kills 260,000-650,000 people and causes 3-5 million cases of severe illness each year. This burden typically falls on the elderly and young children, especially in developing countries. The best way to protect against influenza is through vaccination, although the problem with this is that the current influenza vaccine has to be administered each year and varies in its effectiveness.
The Latest on: Universal flu vaccine
via Google News
The Latest on: Universal flu vaccine
- Researchers Begin Testing Long-Term ‘Universal’ Flu Vaccine on April 18, 2019 at 2:25 pm
After peaking in mid-February, flu rates are on the decline across the state of Texas following a relatively mild season compared to last year, according to the Department of State Health Services. […]
- UW researchers developing permanent flu vaccine score $45M donation on April 17, 2019 at 12:49 pm
That includes a project in development to create a universal flu vaccine that provides permanent immunity from the illness. That in turn, could even break the door wide open for research on ... […]
- UW institute developing lifetime flu vaccine gets $45 million award on April 16, 2019 at 5:13 pm
A universal flu vaccine that immunizes someone for a lifetime. Smart proteins that can identify cancerous cells. Nanomaterial proteins that self-assemble and could be used for solar energy. These are ... […]
- First-In-Human Trial Begins On Universal Flu Vaccine, Older Adults Still Encouraged To Vaccinate on April 16, 2019 at 7:20 am
As researchers at the National Institutes of Health (NIH) begin clinical trials on a “universal” flu vaccine this month, older adults are reminded that immunizations aren’t just for children anymore. ... […]
- BiondVax Universal Flu Vaccine Patent Application Accepted in Australia on April 15, 2019 at 4:50 am
JERUSALEM, April 15, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), announced today that a patent application covering formulation and production processes of the M-001 universal ... […]
- Three more die in Cuyahoga County as flu season extends to spring; universal flu shot being tested on April 10, 2019 at 12:41 pm
More than 50,000 deaths due to influenza have been recorded nationally, according to the CDC. In the future, health providers may be able to offer a universal flu vaccine that gives protection for ... […]
- Experimental ‘Universal’ Influenza Vaccine Being Evaluated in Healthy Volunteers on April 8, 2019 at 9:52 am
A healthy volunteer receives an experimental universal influenza vaccine known as H1ssF_3928 (Image: National Institute of Allergy and Infectious Diseases) The National Institutes of Health (NIH) has ... […]
- Scientists review influenza vaccine research progress and opportunities on April 8, 2019 at 7:40 am
In a new series of articles, experts in immunology, virology, epidemiology, and vaccine development detail efforts to improve seasonal influenza vaccines and ultimately develop a universal influenza ... […]
- First Human Trial of Universal Flu Vaccine Underway on April 7, 2019 at 7:29 am
Researchers are conducting the first-in-human trial of a universal influenza vaccine candidate, the National Institutes of Health (NIH) announced April 3. The NIH's National Institute of Allergy and ... […]
via Bing News